George Simeon, CEO
George Simeon, CEO of Curevo and experienced business executive in the healthcare industry. Has worked globally with Novartis (Switzerland), J&J (Europe), SK Telecom (South Korea), GHX (Europe) and GS1 (USA & Europe). Advisor to early stage companies on growth strategies, strategic alliances, fundraising, and market entry.
Lisa Shelton, Associate Director Clinical Operations
Lisa Shelton, Associate Director of Clinical Operations and Licensed Adult Nurse Practitioner (ARNP). A successful leader in clinical trials investigation and study management in both sponsor and clinical site roles. Sponsor roles in clinical development and operations of first-in-human, phase 1 vaccine, and immunotherapy oncology studies. Experienced sub-investigator for first-in-human, and phase 1-3 trials in infectious disease vaccine and immunotherapy allergy trials.
Soobin Koh, Regulatory Affairs Manager
Soobin Koh, Regulatory Affairs Manager at Curevo. Global regulatory Affairs specialist with experience managing regulatory affairs from product development R&D to pre-market application.
Emma Fritzen, Program Manager
Emma Fritzen is the Program Manager for Curevo, and has proven experience developing and managing contracts, scope and budget in clinical operations. Emma also has experience with GMP and laboratory oversight, management of teams, and Represents Clinical Operations in cross-functional initiatives.
Dr. Yuri Cho, Scientist
Dr. Cho received her PhD in Immunology, focusing on allergy and related immune cells including dendritic cells, basophils and T cells. She has worked with the development of the chickenpox vaccine and is currently working on the herpes zoster vaccine by employing various analytical immunology tools.